Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001736730-25-000059
Filing Date
2025-06-27
Accepted
2025-06-27 16:03:01
Documents
1
Period of Report
2025-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1751054575.html 4  
1 FORM 4 wk-form4_1751054575.xml 4 4083
  Complete submission text file 0001736730-25-000059.txt   5607
Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Higgins Michael J (Reporting) CIK: 0001478521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42365 | Film No.: 251086208

Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Issuer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)